Supply and delivery of semi-solid dosage forms and powders to the national department of health (contract to 31 august 2029)

• Supply and delivery of semi-solid dosage forms and powders to the Department of Health for the period ending 31 August 2029.
• Products are supplied to health facilities against official authorised purchase orders.
• Annexure B sets the minimum data requirements that every invoice for products delivered under this contract must carry.

Contract period

• Ends 31 August 2029

Scope

• Supply and delivery of semi-solid dosage forms and powders to the Department of Health for the period ending 31 August 2029.
• Deliveries are made against official authorised purchase orders, and each invoice may cover only one purchase order number.

Product identification

• Item EAN 13 barcode as it appears on a single sales unit.
• Generic product description and brand name as per the contract circular and the purchase order.
• Contract, addendum and item number referenced as per the contract circular in the format Contract#_Addendum#_Item#, with two placeholders for the addendum number and three for the item number; the item number must correspond to the generic product description.
• Quantity ordered (original requested quantity) and quantity supplied (delivered on that invoice) must both be shown.
• Where a product has more than one batch number, each batch appears on its own line with its quantity.
• Where a product has more than one expiry date, each expiry appears on its own line with its quantity.

Delivery and proof of delivery

• Deliver-to data per purchase order: supplier account number for the Invoice To entity, facility name, demander code, Master Health Facility (MHFL) code, delivery address, name/rank of the official delegated to receive delivery, and the facility telephone number.
• Proof of delivery recorded on the invoice: date of receipt, printed name and PERSAL number of the official receiving and signing, signature, number of cartons received, space for the facility stamp without obscuring any invoice detail, the Goods Received Voucher (GRV) number, and the claim reference number linked to the delivery where applicable.

Invoice pricing

• Unit price must be VAT inclusive and include delivery, taken from the contract circular or addendum, and stated to four decimal places.
• Line total: unit price multiplied by the quantity delivered.
• Summary amounts on the invoice: total excluding VAT, VAT amount, and total including VAT, each to two decimal places.
• Pay office named on the invoice is the entity holding the budget per the purchase order; the invoice must also carry that entity's address, VAT registration number and telephone number.

Supplier identification on every invoice

• Supplier name as per the contract, NDoH supplier code as per the contract circular, CSD registration number (MAAA), company registration number and VAT number.
• Supplier logo and the name of the authorised distributor; the supplier's own details must be used, not the distributor's.
• Supplier physical and postal addresses as per the contract.
• Contact telephone number and e-mail of the department handling public sector queries and returns, plus telephone number and e-mail of the debtors department handling public sector accounts.

Invoice presentation

• Original invoice headed TAX INVOICE; supplier copy and the facility's customer copy headed COPY TAX INVOICE.

Contract period

• Deliveries and the related invoicing run until 31 August 2029.

Invoice minimum data requirements (Annexure B)

• Every invoice for products delivered under this contract must carry the full minimum data set, and only one purchase order number may appear on an invoice.
• Invoice details: unique invoice number, a 1D barcode carrying the invoice number, the invoice date, and page numbering in the form 'x of y'.
• Order details: purchase order number, a 1D barcode carrying the PO number and symbology, the date the order was captured by the supplier, and any special instruction noted on the PO, such as an emergency order or delivery to a specified person.
• Deliver-to and Invoice To data are taken from the purchase order, and the invoice must carry the pay office name, address, VAT registration number and telephone number plus the facility and receiving-official details.
• The invoice must provide for the receiving official's signature and PERSAL number, the number of cartons received, the facility stamp, the GRV number and the claim reference number.

Preference points for specific goals

• Points are only allocated where a valid EME/QSE sworn affidavit is submitted.
• An affidavit that is not completed correctly is invalid and no preference points for specific goals are awarded.
• The points framework applied is that of the Preferential Procurement Regulations, 2022.

B-BBEE evidence by annual turnover

• Up to R10 million (Exempted Micro Enterprise): a qualifying sworn affidavit may be submitted.
• Between R10 million and R50 million (Qualifying Small Enterprise): a qualifying sworn affidavit may be submitted, with the basis for empowering supplier status selected.
• Above R50 million: a valid SANAS-accredited B-BBEE certificate is required; an EME/QSE sworn affidavit does not qualify.

Sworn affidavit contents

• Deponent's full names and identity number as they appear on the identity document.
• Designation (director, owner or member) confirming the deponent is authorised to depose.
• Enterprise name as registered with CIPC, where applicable, and the enterprise business address.
• Percentages of black ownership, black female ownership and designated group ownership.
• Total revenue for the year under review, stating whether audited financial statements or management accounts were used.
• Financial year end used to determine that revenue.
• A single B-BBEE status level of contributor.
• Empowering supplier status, with the QSE basis for it selected.

Validity conditions

• The deponent's signature date and the Commissioner of Oaths' signature date must be the same.
• The Commissioner of Oaths may not be an employee or ex officio of the enterprise, as an interested person cannot commission the affidavit.
• An incorrectly completed affidavit is invalid and forfeits preference points for specific goals.
• Claim is made under the Preferential Procurement Regulations, 2022.

Turnover bands

• EME: annual turnover below R10 million. A qualifying sworn affidavit may be used.
• QSE: annual turnover between R10 million and R50 million. A qualifying sworn affidavit may be used, with the empowering supplier basis selected.
• Above R50 million: a valid SANAS-accredited B-BBEE certificate is required; the EME/QSE affidavit route is not available.

Affidavit must state

• Deponent's names and identity number as per the identity document.
• Designation (director, owner or member) showing authority to depose.
• Enterprise name per CIPC registration, where applicable, and business address.
• Black ownership, black female ownership and designated group ownership percentages.
• Total revenue for the year under review and whether audited financial statements or management accounts were used.
• Financial year end on which that revenue is based.
• One B-BBEE status level of contributor only.
• Empowering supplier status, with the QSE basis selected.

Conditions for validity

• Deponent and Commissioner of Oaths must sign on the same date.
• The Commissioner of Oaths may not be an employee or ex officio of the enterprise; an interested party cannot commission the affidavit.
• A defective affidavit is invalid and no preference points for specific goals are awarded.
• The claim is made under the Preferential Procurement Regulations, 2022.

• Preference points for specific goals are awarded only where the EME/QSE sworn affidavit is validly completed.
• An affidavit completed incorrectly is invalid, and no such preference points are allocated.
• Allocation follows the Preferential Procurement Regulations, 2022.

Supply and delivery of semi-solid dosage forms and powders to the Department of Health, delivered to the DR AB Xuma Building, Pretoria, for the contract period ending 31 August 2029.

Closing

• 16 November 2026 at 11:00.

Briefing (non-compulsory)

• 23 October 2026 at 10:00
• Online via MS Teams.
• Join link: https://teams.microsoft.com/meet/324706389718433?p=Iuv4OChmjF4dal3d91

Bid documents published

• 16 October 2026.

Enquiries

• Submit in time for the department's response to reach bidders before the closing date.

Non-compulsory online briefing on MS Teams, 23 October 2026 at 10:00. Join link: https://teams.microsoft.com/meet/324706389718433?p=Iuv4OChmjF4dal3d91. Attendance is optional.

Enquiries

• Email: [email protected]
• Office hours: 07h30 to 15h30

Bid delivery address

DR AB Xuma Building

1112 Voortrekker Road

Pretoria Townlands 351-JR

Pretoria, 0143

Bid documents

• Department of Health website: www.health.gov.za
• National Treasury e-tender portal

Submission method

• Hand delivery to the Department of Health, DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, 0143.
• Closing time: 11:00 on 16 November 2026.
• Office hours for delivery: 07h30 to 15h30.

Bid documents

• Released on 16 October 2026 and obtainable from the Department of Health website (www.health.gov.za) and the National Treasury e-tender portal.
• On the Department of Health site, use the Tenders tab, then the Pharmaceutical Tenders tab.
• The full bid document contains the returnable document list and the Special Requirements and Conditions of Contract.

Enquiries

• All enquiries, including problems with the registration process, must be emailed to [email protected] early enough for a reply to reach bidders before the closing date.

Returnable forms

• The forms to be completed, signed and submitted are listed in the bid document itself.

Evaluation stages

• Phase I: compliance with the mandatory administrative bid requirements.
• Phase II: compliance with the mandatory product, technical and legal requirements.
• Phase III: B-BBEE compliance, assessed against Section 22 of the Special Requirements and Conditions of Contract.
• Phase IV: recommendation and award.

Bidders must clear each phase in sequence before the bid progresses to the next.

Scope

• Supply and delivery of semi-solid dosage forms and powders to the Department of Health.
• Contract period: up to 31 August 2029.

Delivery point

• Department of Health, DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, 0143.

Product and technical requirements

• Bidders must meet the mandatory product, technical and legal requirements assessed in Phase II.
• The detailed product list, technical standards and legal requirements sit in the bid document and its Special Requirements and Conditions of Contract.

Compliance gates

• Phase I: mandatory administrative bid requirements must be met before the bid proceeds.
• Phase II: mandatory product, technical and legal requirements.
• Phase III: B-BBEE compliance, assessed under Section 22 of the Special Requirements and Conditions of Contract.

B-bbee

• B-BBEE is a scored compliance gate, with the applicable requirements and evidence detailed in Section 22 of the Special Requirements and Conditions of Contract.

Four-phase evaluation:

• Phase I: mandatory administrative compliance.
• Phase II: mandatory product, technical and legal compliance.
• Phase III: B-BBEE compliance per Section 22 of the Special Requirements and Conditions of Contract.
• Phase IV: recommendation and award.

The Department of Health requires supply and delivery of semi-solid dosage forms and powders under a contract running to 31 August 2029. Bidders price the listed items on the HP08-2026SSP_01 Bid Response schedule, per unit and per shipper pack in ZAR, for the estimated quantities covering the full contract period.

Bid response format

• Bids are priced on the HP08-2026SSP_01 Bid Response workbook, one line per bid item.
• The bidder's registered legal name and CSD number are captured on the response schedule.
• Each item is priced twice: delivered price in ZAR per unit and delivered price in ZAR per shipper pack, both to two decimals.

Returnable form

• PBD1: must be completed where any manufacturer, distributor or similar party listed for an item is a third party to the bidder.

Assessment is against the priced response schedule.

• Price: the delivered price per item may not exceed the SEP shown for the corresponding unit on the current contract listing.
• Specification: each item must be marked as conforming or not conforming, with any deviation from specification described in detail.
• Registration: a product registration number and the licence to manufacture medicines (number and expiry date) are required for every bid item.
• Bidder identification: registered legal name and CSD number must appear on the schedule.
• Third-party manufacturing: where a listed manufacturer or similar party is a third party to the bidder, PBD1 must be submitted.

Supply and delivery of semi-solid dosage forms and powders to the Department of Health for the contract period ending 31 August 2029. Quantities shown are the estimates for the full tender period; items are numbered as on the bid response schedule.

Bid items

• Item 1: Adapalene 0.1% cream, 30g; each; 77,160; Class 4
• Item 2: Adapalene 0.1% gel, 30g; each; 34,880; Class 3
• Item 5: Amethocaine 1% topical, 25g; each; 125,990; Procurement Class 1
• Item 9: Benzoyl Peroxide 5% topical, 15–25g; each; 275,910; Procurement Class 2
• Item 10: Benzoyl Peroxide 5% topical, 40–50g; each; 153,890; Procurement Class 2
• Item 18: Bismuth Iodoform Paste, 45g in light protective packaging; each; 36,750
• Item 19: Bismuth combination ointment (per gram: Bismuth Subgallate 22.5mg, Bismuth Oxide 8.75mg, Zinc Oxide 107.5mg) with applicator, 25g; each; 76,540
• Item 20: Bismuth combination suppository (Bismuth Subgallate 59mg, Bismuth Oxide 24mg, Zinc Oxide 296mg); 10 suppositories; 80,230
• Item 22: Caffeine monohydrate powder BP, 100g; each; 1,220
• Item 23: Caffeine monohydrate powder BP, 500g; each; 40
• Item 24: Carbon Dioxide Absorbent with indicator, granules in airtight waterproof container, 4.2–4.5kg; each; 5,970
• Item 31: Coal Tar 5% topical, 400–500g; each; 1,300; Procurement Class 3
• Item 32: Coal tar shampoo, 200–250ml; each; 112,299
• Item 58: Hydrocortisone 1% ointment, 20–25g; each; 2,919,190
• Item 61: Isotretinoin 0.05% gel, 30g; each; 34,880
• Item 63: Lidocaine 2% gel for urethral catheterisation, chlorhexidine free, syringe or tube with nozzle; each; 188,000
• Item 64: Lidocaine 2% cream, 20g; each; 125,990; Procurement Class 1
• Item 84: Podophyllin resin BP, 25g; each; 2,630
• Item 85: Podophyllin solution 7ml (Podophyllin 0.75g, Salicylic acid 0.5g, Benzoin Tincture 4.2g); each; 10,540
• Item 86: Cytological specimen fixative (polyethylene glycol and isopropyl alcohol/ethanol) aerosol, 100g; each; 845
• Item 87: Potassium Chloride BP crystals or crystalline powder, 500g; each; 2,443
• Item 89: Povidone Iodine 10% ointment, 500g; each; 52,240
• Item 92: Povidone Iodine douche, 250ml solution with squeeze bottle and applicator; each; 3,750
• Item 93: Prednisolone Caproate 1.3mg and Cinchocaine 1mg suppository; 12 suppositories; 82,710
• Item 94: Prednisolone Caproate 1.9mg and Cinchocaine 5mg/g ointment, 30g; each; 12,370
• Item 96: Salicylic Acid BP crystals or crystalline powder in well-closed container, 500g; each; 643
• Item 97: Salicylic Acid 15–30% topical application, 10–20ml; each; 9,660
• Item 98: Selenium Sulfide 2.5% suspension, 50ml; each; 674,900
• Item 107: Tetracaine 0.5% ointment for oral use, 10g; each; 30,790
• Item 108: Tretinoin 0.025% gel, 20g; each; 34,880; Class 3
• Item 109: Tretinoin 0.05% cream, 20g; each; 77,160; Class 4
• Item 114: Coal Tar 5% topical, 250–399g; each; 1,300; Procurement Class 3

Carbon dioxide absorbent specification

• Must contain more than 80% Ca(OH)2, no more than 5% NaOH and no more than 5% KOH, and be free of barium salts.
• Must carry an irreversible colour-change indicator showing when CO2 absorption capacity is nearly exhausted.
• Granules must fall between imperial mesh 4 and 8 and may contain 1% hardener by weight.
• The label must state the granule size range, the indicator and its colour change, a warning that the absorbent no longer works once the colour changes, and first aid for accidental exposure to sensitive tissue.
• Containers must be marked with contents, manufacturer name and address, batch number and expiry date.

Product data required for every priced item

• Registered product name; conformance to specification (Y/N) and full details of any deviation.
• Product registration number; licence to manufacture medicines number and expiry date.
• Pack sizes offered: unit pack, shelf pack, and standard units per shipper pack.
• Lead time of 14 calendar days or less; initial lead time of 75 calendar days or less.
• Minimum order quantity; batch size in packs; monthly batch capacity assigned to the item for the contract duration, in batches.
• Whether a technical amendment is needed to meet the bid conditions (Y/N) with details.
• Barcodes: EAN 13 unit pack, EAN 13 shelf pack, ITF14 shipper pack, 2D barcode or similar; NAPPI code.
• Distributor name and address (primary and secondary).
• Manufacturers as listed on the MRC (primary, secondary, tertiary) and whether any is a third party to the bidder.
• API sources 1 to 3: full site name, full address, country and contact.

Pricing format

• Delivered price in ZAR per unit and delivered price in ZAR per shipper pack, each to two decimals.
• Neither price may exceed the SEP on the current listing for the corresponding unit.
• The applicable SEP for the corresponding unit must be reflected on the schedule.
• Currency options for the price build-up: ZAR, USD, GBP, EURO, DKK, CHF, AUD, INR, Yuan or Other.

Price build-up per item

• Percentage of delivered price attributable to: API, formulation, packaging, logistics and gross margin.
• Each of API/raw material, formulation and packaging must be split between local and imported content.

• CSD registration number must be captured on the bid response schedule.
• Product registration number required for each bid item.
• Licence to manufacture medicines: number and expiry date required.
• Manufacturers must be listed on the MRC register; primary, secondary and tertiary manufacturers are declared.
• PBD1 must be completed where any listed manufacturer, distributor or similar party is a third party to the bidder.
• Each item must be declared as conforming or not conforming to specification, with deviations detailed.
• Price per item must not exceed the SEP for the corresponding unit on the current listing.

Closing: 16 November 2026 at 11:00 — delivery to the Pharmaceutical Tender Box.

Online briefing: 23 October 2026 at 10:00 via MS Teams. Attendance is not compulsory.

Bid validity period: 180 days.

Online briefing session via MS Teams on 23 October 2026 at 10:00.

Attendance is not compulsory.

Bid process enquiries

• Email: [email protected]
• Both bidding procedure and technical enquiries are directed to this address; no named contact person or telephone number appears on SBD 1.

Directorate: Access to Affordable Medicines

• Telephone: (012) 395 8130
• Fax: (012) 395 8823/4

Bid issued by: Ms K Jamaloodien, Chief Director: Health Products Procurement, for the Director-General.

Submission address

Addressed to:

The Director-General: Health

Dr AB Xuma Building

1112 Voortrekker Road, Block A

Pretoria Townlands 351-JR

Pretoria, 0187

Delivered to:

Directorate: Affordable Medicines

Dr AB Xuma Building

1112 Voortrekker Road

Pretoria Townlands 351-JR

Pretoria, 0187

Postal address: Private Bag X828, Pretoria, 0001

National Industrial Participation enquiries

• Contact: Ms R Muthan
• Telephone: (012) 394 1288
• Mobile: (066) 301 2051
• Email: [email protected]
• Postal: Department of Trade and Industry, Private Bag X84, Pretoria, 0001, for the attention of Mr Elias Malapane.

Submission method

• Physical delivery into the Pharmaceutical Tender Box at the main entrance of the Department of Health, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, 0187, addressed to the Director-General: Health.
• The tender box is generally accessible during working hours.
• Closing: 16 November 2026 at 11:00. Late bids are not accepted.
• Bid validity: 180 days.

Packaging

• All sets must be in one sealed package marked on the outside with the bid number, the closing date, the bidder's full name and address, a return address and the name of a contact person.
• Set 1: the Invitation to Bid document with every page and form completed in detail.
• Set 2: USB flash drive containing a scanned copy of the completed bid, compiled in the exact sequence of the index.
• Set 3: all Excel spreadsheets on USB flash drive, for uploading purposes.
• Bids must be submitted on the official forms provided and may not be retyped.

Returnable documents

• SBD 1 (Invitation to Bid): bidder, contact and supplier information, signed as the offer cover page.
• SBD 4 (Bidder's Disclosure): discloses employment by an organ of state and any interest in related enterprises; a false disclosure disqualifies the bid.
• SBD 5 (National Industrial Participation): signed acknowledgement of the NIP obligations where the contract has imported content.
• SBD 6.1 (Preference Points Claim Form): claims the 10 specific-goal points on the bidder's B-BBEE status level.
• SBD 7 (Contract Form): completed and signed by the successful bidder on award.
• PBD 1, with PBD 1.1 and PBD 1.2: declares third-party sourcing and attaches the third party's unconditional written undertaking to supply for the contract duration.
• PBD 3 and PBD 3.1: authorises the named signatory to bind a single-entity or multi-entity bidding enterprise.
• PBD 4.1: supplier and contract contact details spreadsheet.
• PBD 5: declares compliance with Good Manufacturing Practice.
• PBD 8: declares compliance with the Special Requirements and Conditions of Contract and the General Conditions of Contract.
• PBD 9.1 and PBD 9.2: directors' profiles, directorships and ownership details for single and multi-entity bidders.
• PBD 10: declares British Pharmacopeia compliance and lists manufacturers.
• PBD 11: declares financial solvency and business rescue status.
• Excel Bid Response Document, proof of CSD registration and SARS tax compliance status.

Disqualification risks

• Bids received after the closing time or delivered to the wrong address.
• Any official form that is unsigned, incomplete or omitted.
• Failure to disclose all CSD-registered active companies linked to directors.
• Being listed on the Register for Tender Defaulters or the List of Restricted Suppliers.

Bids must be submitted on the official forms.

• Set 1: the completed Invitation to Bid document, all pages and forms.
• Set 2: USB flash drive with a scanned copy of the completed bid in the exact sequence of the index.
• Set 3: all Excel spreadsheets on USB flash drive for uploading.
• All sets in one sealed package marked outside with the bid number and closing date, the bidder's full name and address, a return address and a contact person's name.
• Returnable forms: SBD 1, SBD 4, SBD 5, SBD 6.1 and SBD 7 on award; PBD 1 with PBD 1.1 and PBD 1.2, PBD 3, PBD 3.1, PBD 4.1, PBD 5, PBD 8, PBD 9.1, PBD 9.2, PBD 10 and PBD 11; the Excel Bid Response Document; proof of CSD registration and SARS tax compliance status.

Preference point system: 90/10 under the Preferential Procurement Regulations, 2022.

Points split

• Price: 90 points.
• Specific goals (B-BBEE status level of contributor): 10 points.
• Total available: 100 points.
• Minimum qualifying score: none stated.

B-BBEE points

• Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, non-compliant contributor = 0.
• Specific goal: advancement of bidders with higher B-BBEE contribution levels (Status Levels 1 to 4).
• Support: a valid SANAS accredited B-BBEE certificate, or a valid sworn affidavit for an EME or QSE. A missing or invalid support document does not make the bid non-responsive, but scores zero preference points.
• The department may require substantiation of any preference claim before adjudication or at any time afterwards.

Pre-qualification

• CSD registration with a CSD number, or a SARS Tax Compliance Status PIN or printed TCS certificate.
• Bids from persons in the service of the state, or from companies or close corporations whose directors or members are in the service of the state, are not considered.

Scope: supply and delivery of semi-solid dosage forms and powders to the Department of Health for the contract period ending 31 August 2029.

Quantities and item lines: set out in the Bid Response Document, issued as a separate Excel file that the bidder completes and submits electronically.

Product standards

• Where a British Pharmacopeia standard is specified, the offered product must comply with and be manufactured to that standard, and the manufacturer's name, contact details and physical address must be declared.
• The manufacturer must have taken all reasonable steps to confirm there are no outstanding or impending GMP or legal matters that could affect its ability to perform, and must comply with the Medicines and Related Substances Act for the products offered.

Supply continuity: the department must be notified at first knowledge of any circumstance that could interrupt supply.

Third-party sourcing: products obtained from a third party must be declared, together with that party's unconditional written undertaking to supply for the duration of the contract.

Supplier registration: provincial departments of health may require separate supplier registration and province-specific documents.

Good Manufacturing Practice

• The bidder declares that all reasonable steps have been taken to confirm there are no outstanding or impending GMP or legal matters that could materially affect the company's ability to perform.
• The bidder declares compliance with the legal requirements of the Medicines and Related Substances Act for the products offered.
• The department must be informed at first knowledge of any circumstance that could result in interrupted supply.

British Pharmacopeia

• Where a BP standard is specified, the product must comply with and be manufactured to that standard.
• The manufacturer's name, contact details and physical address must be declared.

Pricing: quoted on the Bid Response Document spreadsheet, issued as a separate Excel file and submitted electronically on USB flash drive (Set 3).

Bid validity: 180 days.

Bid security: none stated.

National Industrial Participation

• Contracts with imported content of US$10 million or more carry a NIP obligation of 30% of the imported content.
• The obligation is discharged over seven years through investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing arrangements or research and development.
• Contracts above R10 million must be reported to the Department of Trade and Industry within five working days of award.
• The contractor submits a performance guarantee to the DTI and signs a NIP obligation agreement with the DTI.

Financial standing

• The bidder must declare that it is financially solvent and able to perform, and that it is not under business rescue, liquidation, sequestration, administration or judicial management, with no such application pending.
• Any financial event that could materially affect performance must be reported to the department within five working days.

Contract: the successful bidder completes and signs the written contract form (SBD 7).

Central Supplier Database: bidders must be registered on the CSD; where no SARS TCS PIN is available, a CSD number must be provided.

Tax compliance

• Submit a SARS Tax Compliance Status PIN, or a printed TCS certificate.
• In consortia, joint ventures or sub-contracting arrangements, each party submits its own TCS certificate, PIN or CSD number.

State employees: bids are not considered from persons in the service of the state, companies whose directors are in the service of the state, or close corporations whose members are in the service of the state.

Restricted suppliers: anyone listed on the Register for Tender Defaulters or the List of Restricted Suppliers is automatically disqualified.

Director disclosure: all CSD-registered active companies linked to any director must be disclosed; failure to disclose leads to disqualification.

B-bbee

• Claim the 10 specific-goal points with a valid SANAS accredited B-BBEE certificate, or a valid sworn affidavit for an EME or QSE.
• The EME affidavit applies where annual total revenue is R10 million or less.
• The affidavit must be completed in full and is valid for 12 months from the date the Commissioner of Oaths signs it.
• Level 1 = 10 points, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, non-compliant = 0.

Foreign suppliers: complete the questionnaire on RSA residency, branch, permanent establishment, income source and tax liability; if every answer is no, SARS PIN registration is not required. A foreign bidder must enclose proof of its accredited South African representative.

Returnable forms: SBD 1, SBD 4, SBD 5, SBD 6.1 and SBD 7 on award; PBD 1, 1.1, 1.2, 3, 3.1, 4.1, 5, 8, 9.1, 9.2, 10 and 11; the Excel Bid Response Document; proof of CSD registration and tax compliance.

No CIDB grading, local content percentage or professional registration requirement is stated.

Preference points for specific goals are claimed on the B-BBEE status level of contributor.

• Evidence: a valid SANAS accredited B-BBEE certificate, or a valid sworn affidavit for an EME or QSE.
• Applicable goal: advancement of bidders with higher B-BBEE contribution levels (Status Levels 1 to 4).
• Points: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, non-compliant = 0.
• Missing or invalid evidence earns zero preference points but does not automatically make the bid non-responsive.
• The EME affidavit applies where annual total revenue is R10 million or less; it must be completed in full and is valid for 12 months from the date the Commissioner of Oaths signs it.

The successful bidder must complete and sign the written contract form (SBD 7).

The contract covers supply and delivery of semi-solid dosage forms and powders to the Department of Health for the period ending 31 August 2029.

Bids must be addressed to the Director-General, Department of Health, and deposited in the Pharmaceutical Tender Box at the main entrance of the Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria, before the closing date and time.

Late bids are not accepted for consideration.

Bid validity period: 180 days.

If a contract is awarded, the supplier must provide full detail for registration or verification; provincial departments of health may require separate registration and province-specific documents.

Any change to the supplier details submitted with the bid must be reported to the National Department of Health in writing.

Financial solvency declaration (PBD 11)

• The bidder must confirm it is financially solvent with sufficient resources to perform the contract.
• The bidder must not be under business rescue, provisional or final liquidation, sequestration, administration or judicial management, and no application for business rescue, liquidation, compromise with creditors or similar proceedings may be pending.
• Any financial event during the bid validity period or contract term that could materially affect performance must be reported to the department within five working days.
• A false declaration may result in disqualification, contract termination, referral to National Treasury for restriction and further legal action.

The tender is evaluated on the 90/10 preference point system under the Preferential Procurement Regulations, 2022.

• Price: 90 points.
• Specific goals (B-BBEE status level of contributor): 10 points.
• Total: 100 points.
• B-BBEE points: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, non-compliant = 0.
• Specific goal: advancement of bidders with higher B-BBEE contribution levels (Status Levels 1 to 4).
• Support: a valid SANAS accredited B-BBEE certificate, or a valid sworn affidavit for an EME or QSE.
• Missing support does not render the bid non-responsive, but scores zero preference points.

Bid content

• The covering letter must set out the bidder's position regarding tax, licence to manufacture and certificates.

Format and packaging

• Provide a digital copy of the completed bid on a USB flash drive or storage device (Sets 2 and 3).
• Save each compilation sequence as its own file, using the index admin-code abbreviations in the file name.
• Sort, file and submit the documents in exactly the order set out in the checklist.
• If a document does not apply, mark it "N/A" and give a reason for leaving it out; a blacked-out N/A field is not an acceptable answer.

Administrative documents to accompany the bid

• Covering letter, indicating the status of tax, licence to manufacture and certificate matters.
• Bid/file index.
• PBD 4.1 contact details of the bidder.
• CIPC notice of change of directors, and proof of any ceding, merger, acquisition or name change.
• PBD 9.1 entity directors (single bidding entity) or PBD 9.2 multi-entity bid, each with certified copies of the directors' identity documents.
• Licence annexures and DA02 product list; MRC annexures issued by SAHPRA; variation summary for any MRC change as prescribed by the current SAHPRA BAU variations communication.
• PBD 1 third-party authorisation declaration, PBD 1.1 list of products sourced from third parties, and PBD 1.2 third-party written undertaking or formal third-party letter.
• Original package insert or QR code with the MCC- or SAHPRA-approved professional information for every product offered.
• Proof of sample submission and the bidder's item list of products offered.

Mandatory documents

• PBD 3 bid signature authorisation, original or certified copy.
• SBD 1 invitation to bid (bidding entity).
• CSD registration report.
• SARS tax clearance pin.
• CIPC registration certificate.
• SBD 4 declaration of interest (bidding entity).
• SBD 6.1 preference points claim, with the points claimed entered in the table and space provided.
• Valid B-BBEE certificate from a SANAS-accredited agency, or a sworn EME affidavit, or a sworn QSE affidavit on the template provided, as applicable.
• PBD 11 declaration of financial solvency and business rescue status.
• PBD 5 declaration of compliance with Good Manufacturing Practice, signed by the PBD 3 authorised signatory.
• SBD 5 national industrial participation programme (bidding entity).
• Valid licence to manufacture or import in the bidder's own name, with all annexures, certified.
• Valid licence to manufacture or import for the local manufacturing sites listed on the bidder's MRC, with all annexures, certified.
• Valid licence to manufacture, import, distribute or wholesale complementary medicines in the bidder's name, certified.
• Valid licence to manufacture, import, distribute or wholesale a medical device or in vitro diagnostic in the bidder's name, certified.
• Valid medicine registration certificates for the products offered, each marked with its item number and filed in numerical order, certified.
• PBD 8 declaration of compliance with the special requirements and conditions of contract and the general conditions of contract, signed by the PBD 3 authorised signatory.
• Signed copy of the special requirements and conditions of contract, initialled on every page.
• Signed copy of the general conditions of contract, initialled on every page.
• Signed Excel bid response (pricing schedule).
• Multi-entity bids (partnership, joint venture or consortium): certified copy of the agreement between the entities, plus all other mandatory documents listed in Section 13.

Sequence

• Documents are checked first: administrative items and then the mandatory items listed in the bid checklist.
• Preference points are claimed by the bidder on SBD 6.1, with the points entered in the table and space provided.

Decisive gates

• The Excel bid response (pricing schedule) must be signed in the space provided; an unsigned pricing schedule will not be considered for evaluation.
• A mandatory document that is missing, or an exclusion that is not properly marked "N/A" with a reason, puts the bid at risk of disqualification.
• Documents marked mandatory for the bidding entity must be submitted by the bidding entity itself.

Scope

• Supply and delivery of semi-solid dosage forms and powders to the National Department of Health for the period ending 31 August 2029.

Product requirements

• Only products registered with SAHPRA may be offered; a valid medicine registration certificate is required per product.
• Each MRC must be marked with the relevant item number and filed in numerical order.
• The original package insert or a QR code carrying the MCC- or SAHPRA-approved professional information must be provided for every product offered.
• MRC annexures issued by SAHPRA must accompany the registration certificates.
• Where the MRC has changed, a valid variation summary issued under the current SAHPRA BAU variations communication must be provided.
• Samples must be submitted, and proof of that submission must accompany the bid.
• The bidder must submit its own item list of the products offered.
• Manufacturing must comply with Good Manufacturing Practice, declared on PBD 5.
• Products sourced from a third party require a third-party authorisation declaration, a product list and an unconditional written undertaking from that third party.
• Where the bidder's MRC lists local manufacturing sites, the corresponding manufacture or import licence for those sites must be provided; locally produced products are preferred.

Pricing

• The bid must include the signed Excel bid response (pricing schedule); an unsigned pricing schedule is excluded from evaluation.

Financial standing

• PBD 11 declaration of financial solvency and business rescue status is a mandatory returnable document.

Registration and tax

• CSD registration report, mandatory.
• CIPC registration certificate, mandatory.
• CIPC notice of change of directors, administrative, plus proof of any ceding, merger, acquisition or name change.
• SARS tax clearance pin, mandatory.

Empowerment

• Valid B-BBEE certificate from a SANAS-accredited verification agency, required where applicable.
• Sworn affidavit for an Exempted Micro Enterprise, required where applicable.
• Sworn affidavit for a Qualified Small Enterprise on the template provided, required where applicable.

Authorisation

• PBD 3 bid signature authorisation, original or certified copy, mandatory; the authorised signatory signs PBD 5 and PBD 8.
• Multi-entity bids require a certified agreement between the entities plus the mandatory documents in Section 13.

Licensing and product compliance

• Licence to manufacture or import in the bidder's name, with annexures, certified, mandatory.
• Licence to manufacture or import for the local manufacturing sites on the bidder's MRC, certified, mandatory; locally produced products are preferred.
• Licence to manufacture, import, distribute or wholesale complementary medicines in the bidder's name, certified, mandatory.
• Licence to manufacture, import, distribute or wholesale a medical device or in vitro diagnostic in the bidder's name, certified, mandatory.
• Medicine registration certificates for all products offered, certified, item-numbered and numerically filed, mandatory.
• PBD 5 declaration of compliance with Good Manufacturing Practice, mandatory.
• PBD 8 declaration of compliance with the special requirements and conditions of contract and the general conditions of contract, mandatory.
• SBD 5 national industrial participation programme, mandatory for the bidding entity.